A

PSIL

AdvisorShares Psychedelics ETF

17.48

+0.17+0.95%

After Hours: 17.48 0.00 0.00%16:00 04/08 EDT

1D

5D

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE17.69/17.31

TODAY RANGE17.37-17.69

VOL5.09K

TOTAL ASSET20.67M

52 WEEK RANGE8.70-19.65

% TURNOVER0%

NAV17.67

EXPENSE RATIO(NET)1.00%

1Y RETURN(CUM.)94.70%

DIVIDEND1.879

DIV YIELD10.75%

EX-DATE12/22/2025

% RANGE1.27%

INCEPTION DATE09/15/2021

BETA--

LOT SIZE1

LIPPER RATING-

News

Benzinga·03/16 17:35
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
Benzinga·02/17 14:12
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Seeking Alpha·01/22 12:15
2025 ETF Wrap-Up And What To Expect In 2026
NASDAQ·12/31/2025 16:00
Best-Performing Active ETFs of 2025
Seeking Alpha·09/22/2025 10:13
AdvisorShares Psychedelics ETF declares quarterly distribution of $0.0200
Benzinga·08/05/2025 18:25
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
NASDAQ·06/20/2025 14:00
5 ETFs That Beat the Market in the First Half of 2025
Benzinga·06/11/2025 19:39
'Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug' - Marijuana Moment
Benzinga·06/10/2025 16:57
"Colorado Governor Says Bill He Signed Allowing Psychedelic Convictions To Be Pardoned Marks A Step 'Towards A Fairer Future'" - Marijuana Moment
Benzinga·06/06/2025 14:50
'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment
Benzinga·05/24/2025 20:11
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others